See Earth's Forests as Never Before in Biomass Satellite's First Images
On June 23 the ESA released the mission's first images, which showcase its unique capability to peer through dense vegetation to study our planet's forests and other ecosystems as never before. Using cutting-edge radar technologies, the satellite is on a five-year mission to survey forests across sprawling swaths of the globe, looking beneath their canopies to accurately assess their total woody biomass—trunks, limbs, stems, and so on. By measuring all that material and how it's changing over time, scientists can better monitor deforestation trends and track the flow of carbon through ecosystems to enhance our understanding of Earth's rapidly changing climate. The satellite is still in its six-month-long commissioning phase, but now we have a taste of what is to come.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
The image shown above displays a section of the Amazon rainforest in Bolivia with the Beni River meandering through. Each color represents a different ecosystem feature: black for rivers and lakes, pink for wetlands and floodplains, green for rainforests, and purple for grasslands. The World Resources Institute's Global Forest Review ranks Bolivia among the top 10 countries with the most tree cover loss between 2001 and 2024. During this time, Bolivia lost the equivalent of 15 percent of the total forest cover it had in 2000, in large part to encroaching agricultural plots and cattle ranches. These images and their associated data can help researchers keep careful tabs on deforestation and its impacts on local and global ecosystems.
The image below highlights the satellite's power by comparing its observations with those gathered by a Biomass predecessor, ESA's Copernicus Sentinel-2 mission, in the same location. The new pictures represent a significant increase in detail that is primarily owed to Biomass's main instrument: the P-band synthetic aperture radar. P-band radio waves are longer than others more typically used in such radar systems, allowing them to pass through layers of foliage, soil and other materials to create accurate three-dimensional maps of otherwise hidden landscape features.
Because of engineering challenges as well as diplomatic ones, this is the first time P-band radar has been used in orbital Earth observations—the P-band radio frequency is typically reserved for American and European missile-detection systems. (In order to ensure it will not interfere with the U.S. Department of Defense's space-object-tracking radar systems, Biomass will not observe North and Central America, Europe, and some Arctic regions.)
The next three images below demonstrate just how deep the P-band radar can go. They display topographic features of rainforests in Indonesia, the Sahara Desert in Chad and the Transantarctic Mountains adjacent to the Nimrod Glacier in Antarctica, respectively.
Pictured above is Indonesia's mountainous Halmahera rainforest, featuring rugged topography shaped by outpourings from the numerous volcanoes that pockmark the region. One of them, the active volcano Mount Gamalama, can be seen off the coast on the far left.
Though the main goal of the Biomass satellite is to catalog forests, it will also study other environments.
Above is a portion of the Tibesti Mountains situated in the central Sahara Desert in northern Chad. Able to map features as far as five meters beneath dry sand, the satellite can reveal ancient geologic details, such as dried-up riverbeds and lakes, now buried below the Sahara's ever-shifting dunes. These data can help researchers understand past ecological changes in such regions—and could even help unearth hidden pockets of precious groundwater in arid, remote deserts.
Biomass can also penetrate into ice, pictured below, and collect information about ice-sheet structure and movement that could be used to better understand what controls the slide of glaciers into the sea.
Below, another image features jungle-covered terrain in Gabon and prominently displays the Ivindo River, which nurtures the surrounding rainforest. The predominantly green color of the image indicates dense vegetal growth—a sign of a healthy rainforest.
The final image shown here, below, is the very first one the satellite produced. It displays a portion of the Amazon rainforest in Brazil, highlighting the topography of the region alongside features such as rivers, wetlands and grasslands.
Only a small portion of the vast Amazon has been studied in-depth and on the ground. This is largely because of its scale and the associated difficulty of reaching some of its most remote regions. Innovative satellites like Biomass could greatly increase our knowledge of these overlooked places and similar ones around the world, helping researchers better understand—and protect—our changing planet and its myriad beautiful ecosystems.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
4 hours ago
- Newsweek
'Extremely Severe' Obesity on the Rise in US Children—Study
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Extremely severe obesity among American children has increased more than threefold over the past 15 years, with new research published on the JAMA Network, highlighting disturbing trends in prevalence and related health complications. Researchers analyzed national health data from 2008 to 2023, uncovering a surge in the most severe obesity categories for U.S. children aged 2 to 18 years old. Newsweek has reached out to the authors of the study via email Sunday during non-working hours for further comment. Why It Matters The study comes as the nation faces persistent challenges combating childhood obesity, signaling what authors have called a "public health emergency" with wide-ranging medical and economic consequences for future generations. "The findings underscore the urgent need for public health interventions against pediatric obesity in the U.S.," authors Eliane Munte, Xinlian Zhang, Amit Khurana, and Phillipp Hartmann wrote in the study. The sharp upswing in extremely severe obesity among children raises the risk of developing serious medical conditions—including type 2 diabetes, steatotic liver disease, also known as fatty liver disease (MASLD), metabolic syndrome, and cardiovascular disease. According to the U.S. Centers for Disease Control and Prevention (CDC), as of April 2024, approximately 1 in 5 children—14.7 million—are already classified as obese, with the burden disproportionately affecting racial minorities and lower-income families. Untreated, these complications can persist into adulthood, multiplying risks for chronic disease and shortened life expectancy. What To Know The study evaluated data from 25,847 children and teens, drawing from the National Health and Nutrition Examination Survey (NHANES) between 2008 and 2023. Obesity was categorized using percentiles based on age and sex, and researchers identified a 253 percent relative increase in extremely severe obesity. Adolescents aged 16 to 18 and non-Hispanic Black children were especially affected. According to the CDC, the prevalence of obesity in U.S. children and teens aged 2-19 years increased from 19.46 percent in 2008 to 22.52 percent in 2023. Several factors have fueled the rise in pediatric obesity, including decreased physical activity, increased screen time, and greater access to high-calorie, low-nutrient foods. Researchers noted that these issues intensified during the COVID-19 pandemic, with children experiencing a nearly doubled rate of annual weight gain between 2019 and 2021 compared to prior years. "The monthly rate of BMI increase nearly times faster after the virus appeared," Dr. Alyson Goodman of the CDC said in the British Medical Journal (BMJ) in 2021, highlighting the influence of pandemic-era disruptions. Economic and social disparities also contribute significantly to who is most affected. The CDC reported higher obesity rates among children in families below 130 percent of the federal poverty level around 25 percent, compared with those in wealthier households at 11.5 percent. Unequal access to healthy foods, safe recreational spaces, and adequate medical care also play roles, the CDC said in 2024. The JAMA study found significantly higher odds of children developing MASLD (a fatty liver disease), diabetes or prediabetes, metabolic syndrome, insulin resistance, and early signs of heart disease. Left unchecked, these conditions can lead to cirrhosis, liver cancer, and major cardiovascular events later in life. In 2024, the CDC estimated the annual medical cost of childhood obesity at $1.3 billion, underscoring the seriousness of the crisis. A beam scale is seen in New York on April 3, 2018. A beam scale is seen in New York on April 3, 2018. AP Photo/Patrick Sison, File What People Are Saying The authors of the study wrote in the conclusion: "The findings of this study with over 25,800 participants provide robust evidence supporting extremely severe obesity specifically as a public health emergency. The association with metabolic and cardiovascular complications necessitates urgent public health action, such as early prevention, targeted education, and the mobilization of resources." What Happens Next? The authors called for "urgent public health interventions" and proposed a multi-layered approach, including preventive education, improved access to nutritious foods, and equitable health care.
Yahoo
7 hours ago
- Yahoo
Trump Wants to Shut Down Several Perfectly Good Spacecraft Orbiting Mars for No Reason
The scientific community was appalled by the news that president Donald Trump's administration was looking to deal a devastating blow to NASA's science budget. In its 2026 budget request, released last month, the White House announced it was looking to more cut funding for NASA's science directorate by more than half, leading to overwhelming criticism from the scientific community, as well as from both Republican and Democrat lawmakers. The "skinny" budget calls to end operations of several spacecraft currently orbiting Mars, the Washington Post reports — including Mars Odyssey, a probe that has been orbiting the Red Planet for a record 24 years, and the MAVEN (Mars Atmosphere and Volatile EvolutioN) mission, which has been studying the planet's atmosphere for over a decade. It would also strip all funding for the European Space Agency's Mars Express mission, which was launched in 2003, as laid out by Science earlier this year. Despite their old age, all three missions are still collecting valuable data about the planet and relaying important communications from NASA's rovers currently roaming its rugged surface. Experts have warned that simply giving up on them would be an enormous waste. Even planned trips to the Martian surface could be erased in their entirety, including NASA's flagship — but immensely costly — Mars Sample Return mission, which has already led to heated discussions surrounding its hefty budget during the Biden administration. Alongside almost all major NASA science missions, abruptly ending the agency's operations in Mars' orbit could deal a devastating blow to the United States' space program overall, an enormous self-inflicted wound that could give adversaries, including China and Russia, room to catch up and dominate in space. "This is a tragic mistake for the new administration," Southwest Research Institute scientist and former NASA science chief Alan Stern told Science earlier this year. But not all is lost. As widely expected, the proposed budget has faced an enormous amount of resistance in Congress, with members from both sides of the aisle calling for a far less brutal budget. Most recently, the Senate's appropriations committee revealed a counteroffer that would keep NASA's existing $24.9 billion budget largely intact for 2026. Even NASA's staffers have taken to protesting outside of NASA's headquarters late last month, waving signs that read "Save NASA." It's not hard to see the Trump administration's prioritizing of human spaceflight, setting aside a whopping $1 billion in new investments for Mars-focused programs. But by gutting most major science missions, the White House could throw a major wrench in those plans as well, potentially blacking out communications by needlessly killing off spacecraft already in the planet's orbit. Besides, now that Trump has called it quits with his frenemy Elon Musk, who controls SpaceX and its Mars-bound Starship rocket, the administration could face a major uphill battle in sending the first humans to the Red Planet. More on NASA: Democrats and Republicans Unite in Last-Ditch Effort to Save NASA Solve the daily Crossword
San Francisco Chronicle
9 hours ago
- San Francisco Chronicle
The U.S. is losing its biotech edge over China — and that's bad news for the Bay Area
From gene therapies to cancer breakthroughs, California has been the driving force behind America's biotechnology industry. But today, that edge is slipping. A National Security Commission on Emerging Biotechnology report to Congress in April stated that the U.S. is dangerously close to falling behind China in biotechnology innovation, and called for urgent investment and strategic coordination to maintain global leadership. Genentech's founding in 1976 in South San Francisco marked the start of the modern biotech era, and, ever since, California has been at the forefront of countless scientific discoveries and medical innovations. However, recent funding cuts and an overreliance on China for manufacturing pipelines leave our nation vulnerable. As the report urges, the U.S. must prioritize biotechnology at the national level or risk relying on China to use this strategic power for good. In 2011, the Chinese government declared biotechnology a ' strategic emerging industry ' and has since committed billions to secure dominance in areas like synthetic biology, gene editing and biomanufacturing. In 2024 alone, China conducted over 7,100 clinical drug trials, surpassing the United States and accounting for nearly 40% of global trial activity. Despite U.S. tariffs under the Trump administration designed to counter China's economic influence, China's gross domestic product has remained strong, fueling even greater investment in strategic sectors like biotechnology. By contrast, the U.S. continues to lose ground, constrained by outdated regulatory frameworks and a lack of coordinated federal strategy. While China is building a biotech empire with deliberate, state-backed coordination, the U.S. is stuck playing defense with shrinking budgets. U.S. federal support for biomedical research is slipping, with the budget for the National Institutes of Health facing a 40% cut in the coming year. For a region like the Bay Area, home to some of the world's most promising biotech startups and research institutions, these cuts have a direct toll, including the termination of $314 million in funding that was to be used to train the next generation of biomedical and health researchers. Major institutions like UCSF, Stanford and UC Berkeley are now bracing for delayed projects, staffing freezes and reductions in early-career fellowships that are vital to sustaining long-term innovation. On a national level, promising studies have been halted midstream, leaving research gaps in breakthrough treatments for cancer, Alzheimer's disease and other major infectious diseases that impact millions of Americans. When U.S. investment in domestic biotech falters, it slows innovation at home and creates an opening for global competitors to step in. China's government is strategically positioning its biotech sector to fill the gap left by stalled American research. Just last month, U.S. pharmaceutical firms signed 14 licensing deals with Chinese biotech companies worth up to $18.3 billion, underscoring our growing dependence on China's rapidly maturing R&D capabilities. This shift carries significant implications for California. It is home to over 16,500 life sciences companies and establishments, more than any other state, according to the California Biotechnology Foundation. The state directly employs more than 466,000 workers and generates more than $414 billion in annual economic output. In 2023, California led the nation in venture capital investment, raising over $34 billion for life science companies. Further, California accounted for 40% of all U.S. life sciences patents filed in 2023, and more bioscience patents are issued to California researchers than to those in any other state. Losing ground to China isn't just an economic risk; it's also a national security threat that could reshape who controls the future of health care. While the U.S. system is built on competition and patient outcomes, China's state-controlled model prioritizes strategic control and global influence. In America, ethical safeguards, transparency and regulatory review shape medical progress. In China, the government's control allows for faster approvals but also looser oversight, creating the risk of untested or misused science. The National Security Commission on Emerging Biotechnology warned that China's biotech advances could be weaponized — from battlefield-ready biologics to more nefarious applications. As a scientist working in biotechnology in the Bay Area, I understand that California plays a central role in this global race. From early-stage research in university labs to large-scale manufacturing by leading biotech firms, the state's infrastructure, talent and capital drive America's competitiveness. The Bay Area remains one of the most dense and productive biotech ecosystems in the world, thanks to its concentration of top-tier research institutions, world-class hospitals, a culture of entrepreneurship and the ability to attract the world's best and brightest to its academic and industrial ecosystem. But even here, the warning signs are hard to ignore. Federal NIH cuts have already disrupted major research projects at UC campuses, impacting our ability to attract talented students to our graduate and postdoctoral research programs, while venture capital is increasingly eyeing faster-moving regulatory environments abroad, preferring to license in late-stage assets from China instead of funding early-stage research at home. If Washington fails to prioritize a national biotech strategy, California's innovation engine could slow just as competitors abroad gain momentum. The state's economic future, public health leadership and ability to attract global talent are all at stake. China is no longer a distant biotech challenger and is actively reshaping the industry with its speed, regulatory agility and cost-efficiency, shifting the innovation center of gravity away from the U.S. The National Security Commission on Emerging Biotechnology has made clear that this is not just a matter of competition, but a strategic threat with long-term consequences for public health and national security. If America is to remain a global leader in biotechnology, we must urgently invest in our domestic research ecosystem and rebuild the infrastructure that has powered decades of discovery or be forced to surrender it to a rival that plays by different rules. Ash Jogalekar is a scientist and science writer based in the Bay Area. He is a scientist in residence at the Oppenheimer Project and works on emerging threats and technology risks in areas like biotechnology and AI.
